Parkinson’s Disease

Alterity Therapeutics (ATHE.Q) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company’s patent application No.17/239,375. “As the scientific…
Acorda Therapeutics (ACOR.Q) announced today that it has entered into a distribution and supply agreement with Esteve Pharmaceuticals to commercialize INBRIJA® 33 mg in Spain.     “We are…